Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.36 USD | +1.21% | +0.16% | +50.67% |
05-03 | Oppenheimer Adjusts Kymera Therapeutics Price Target to $52 From $53 | MT |
05-02 | Kymera Therapeutics Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Trading Ideas